GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...
Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...
Serena Williams is famous for her legendary tennis career, with 23 Grand Slam titles and four Olympic gold medals. From today, she'll also be known as a GLP-1 user. The former tennis champion is ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Women who used a GLP-1 before pregnancy were more likely ...
A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat diabetes ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Diabetes management-dose GLP-1 use reduces recurrent ...
About one in eight U.S. adults (12%) say they are currently taking a GLP-1 medication such as Ozempic or Wegovy for weight loss, diabetes, heart disease or another chronic condition, a new KFF Health ...
The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using GLP-1 agonists for weight loss skyrockets, according to data from Gallup.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results